75 FR 242 pg. 78999 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE), Funding Opportunity Announcement (FOA) DD11-002, Initial Review
Type: NOTICEVolume: 75Number: 242Page: 78999
FR document: [FR Doc. 2010-31778 Filed 12-16-10; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE), Funding Opportunity Announcement (FOA) DD11-002, Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 10 a.m.-5 p.m., March 10, 2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of "Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE), FOA DD11-002."
Contact Person for More Information: Donald Blackman, PhD, Scientific Review Officer, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, Georgia 30341, Telephone: (770) 488-3023, e-mail: DBY7@cdc.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: December 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2010-31778 Filed 12-16-10; 8:45 am]
BILLING CODE 4163-18-P